Luca Mastorino

66PUBLICATIONS
83CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Medical bacteriologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (66)

|Sep 29, 2026
Real-World Strategies for Biologic Dose Escalation and Reduction in Psoriasis and Psoriatic Arthritis: A Systematic Review.

|Sep 25, 2026
Omalizumab Discontinuation in Chronic Spontaneous Urticaria: Effectiveness and Predictors of Response and Relapse Comparing Abrupt Cessation and Dose Spacing in a Retrospective Real-Life Study.

|Aug 26, 2026
Real-World Effectiveness of Secukinumab in Congenital Ichthyoses: A Retrospective Monocentric Case Series.

|Mar 28, 2026
Pharmacomicrobiomics in Psoriasis: Microbiome-Drug Interactions Across Systemic Treatments.

Umberto Santaniello, Luca Mastorino, Valentina Pala

|Dec 30, 2025
Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies.

Marta Marino, Francois Rosset, Alice Nervo

|Nov 13, 2025
The Central Role of Th2 Immune Response in Inflammatory Dermatoses: From Pathogenesis to Targeted Therapies.

Valentina Pala, Francois Rosset, Luca Mastorino

Pageof 11

Frequent Collaborators

45 joint publications

Simone Ribero

21 joint publications

Pietro Quaglino

8 joint publications

Francois Rosset

8 joint publications

Niccolò Siliquini